Arthur C. Butcher - May 2, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP& Grp Pres, MedSurg & APAC
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
May 2, 2023
Transactions value $
-$49,303
Form type
4
Date filed
5/3/2023, 04:56 PM
Previous filing
Mar 24, 2023
Next filing
Jun 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +2.1K +9.14% $0.00 25.1K May 2, 2023 Direct F1
transaction BSX Common Stock Tax liability -$49.3K -932 -3.72% $52.90 24.2K May 2, 2023 Direct
holding BSX Common Stock 2.55K May 2, 2023 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -2.1K -24.99% $0.00 6.31K May 2, 2023 Common Stock 2.1K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.